2Bénichou C. Criteria of drug-indueed liver disorders. Report of an international consensus meeting [ J ]. J Hepatol, 1990, 11 (2) : 272-276.
3Danan G, Bénichou C. Causality assessment of adverse re- actions to drugs- Ⅰ. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries [ J]. J Clin Epidemiol, 1993, 46 ( 11 ) : 1323-1330.
4Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-Ⅱ. An original model for validation of drug causality assessment methods : case reports with positive rechallenge [ J ]. J Clin Epidemiol, 1993, 46 (11) : 1331-1336.
5Venulet J. Recognition and assessment of adverse drug reactions in children [J]. Bratisl Lek Listy, 1991, 92 (11): 540-543.
6Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions [ J ]. Clin Pharmacol Ther, 1981, 30 (2) : 239-245.
7García-Cortés M, Lucena MI, Pachkoria K, et al. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury [ J ]. Aliment Pharmacol Ther, 2008, 27 (9) : 780-789.
8Shapiro MA, Lewis JH. Causality assessment of drug-induced hepatotoxicity: promises and pitfalls [ J ]. Clin Liver Dis, 2007, 11 (3):477-505.
9Mafia VA, Vietorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis [J]. Hepatology, 1997, 26 (3) : 664-669.
10Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions [ J]. J Hepatol, 2000, 33 (6): 949- 952.
